Canada markets closed

Sorrento Therapeutics, Inc. (SRNE)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0140-0.0010 (-6.67%)
At close: 03:18PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 8.27M
Enterprise Value 135.23M
Trailing P/E N/A
Forward P/E 1.10
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.12
Price/Book (mrq)N/A
Enterprise Value/Revenue 2.10
Enterprise Value/EBITDA -0.25

Trading Information

Stock Price History

Beta (5Y Monthly) 2.29
52-Week Change 3-93.72%
S&P500 52-Week Change 323.57%
52 Week High 30.4190
52 Week Low 30.0001
50-Day Moving Average 30.0200
200-Day Moving Average 30.0830

Share Statistics

Avg Vol (3 month) 3313.74k
Avg Vol (10 day) 3148.37k
Shares Outstanding 5551.28M
Implied Shares Outstanding 6551.28M
Float 8538.99M
% Held by Insiders 10.89%
% Held by Institutions 10.07%
Shares Short (Jan 31, 2023) 464.56M
Short Ratio (Jan 31, 2023) 44.96
Short % of Float (Jan 31, 2023) 411.96%
Short % of Shares Outstanding (Jan 31, 2023) 411.84%
Shares Short (prior month Dec 30, 2022) 461.44M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Aug 01, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Jun 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-510.93%

Management Effectiveness

Return on Assets (ttm)-40.81%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)64.27M
Revenue Per Share (ttm)0.13
Quarterly Revenue Growth (yoy)31.10%
Gross Profit (ttm)N/A
EBITDA -341.59M
Net Income Avi to Common (ttm)-548M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)80.64M
Total Cash Per Share (mrq)0.15
Total Debt (mrq)207.6M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.41
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-234.63M
Levered Free Cash Flow (ttm)-57.53M